BACKGROUND: Coronary artery disease continues to be one of the leading causes of death and disability around the globe, challenging the efficacy of currently applied schemes to predict the risk for future coronary events. In fact, algorithms such as the Framingham risk score that are based on traditional risk factors like hypertension and dyslipidemia are not very sensitive, leaving a majority of the population at intermediate risk.
Background
Both in the developed and developing countries, cardiovascular diseases continue to be a major cause of morbidity and mortality. 1, 2 Is it estimated that approximately 1 million
Americans and about 19 million people around the world suffer from either acute coronary syndrome or sudden cardiac death; a significant proportion of these are in otherwise asymptomatic patients. 3, 4 Annually, an estimated 540 000 individuals in the Unites States experience a myocardial infarction and over 515 000 deaths are caused by coronary artery disease. This underscores the importance of diagnosing and treating the high-risk predisposing condition that underlie these events. The high risk is conferred by multiple varying abnormalities in the coronary blood vessels, myocardium, and in the blood that predispose patients to the adverse cardiac events. Among these, coronary atherosclerotic plaques have been a focus of major interest. It is estimated that plaque rupture and subsequent thrombotic occlusion of coronary blood vessels account for up to 70% of sudden coronary deaths. 4 Plaque size, intimal thickness, extent of fibrous cap and lipid core are characteristics that are related to the risk of actual plaque rupture and subsequent adverse events. 5 It is interesting to note that although stable anginal symptoms are more common with stenotic plaques, nonstenotic plaques are actually not only far more prevalent, they account for more ruptured plaques subsequently leading to coronary events. 6 While coronary angiography remains the cornerstone for the detection and treatment of occlusive coronary artery stenosis, over 60% of myocardial infarctions and sudden cardiac deaths are caused by atherosclerotic plaques that are associated with a luminal narrowing of less than 50%. 5 Stages of coronary artery disease development
Endothelial dysfunction
Endothelial dysfunction related to changes in endothelial structure and function in response to various pathologic stimuli is one of the earliest vascular abnormalities seen in the atherosclerotic process. These stimuli may be related to abnormalities in lipid profile, leukocytes, a variety of plasma growth and thrombotic factors, and other vasoactive substances. Endothelial dysfunction can be identified by vascular ultrasound as impairment in the endotheliumdependent vasodilation and is related to the presence of atherosclerotic risk factors like dyslipidemia, diabetes, hypertension, and smoking. In addition, endothelial dysfunction has been shown to predict coronary events in patient groups independently of risk factors 7 and has been suggested to account for acute coronary syndrome in patients without occlusive coronary disease. However, this measurement is highly variable and may not be used to predict individual patient risk.
Atherosclerosis-prone areas
The normal coronary vessel intima is covered by endothelial cells and it also contains muscle cells, macrophages, mast cells, and extracellular matrix. Nonobstructive intimal thickening is often seen in response to mechanical forces such as pressure, stretch or tension, and shear stress. Such adaptations are common at bifurcations as the shear and tensile stresses are not uniformly distributed. However, diffuse thickening may develop in relatively straight arterial segments also with evenly distributed stresses. In the presence of other atherosclerotic stimuli, adaptive intimal thickening becomes prone to development of atherosclerosis. 
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Calcification
Calcification within the atherosclerotic plaques is common and increases with age. 8 Both lipid-and collagen-rich plaques may calcify. Substantial data both in vivo and ex vivo suggests that coronary calcification is a marker for the overall atherosclerotic plaque burden but does not correlate with the degree of stenosis or its vulnerability for sudden occlusion. In fact, the heavily calcified plaques may represent a more stable form of atherosclerotic plaque than the noncalcified plaques. However, coronary calcification correlates with the overall amount of atherosclerotic plaque. 9 Thus, it may be an indirect marker for noncalcified plaques the higher the number of plaques, the greater the chance that one of them will rupture and subsequently may identify patients at increased risk of a heart attack. Characteristics of coronary plaque such as the amount, distribution, and composition of atherosclerotic plaque have been investigated with respect to their predictive value for cardiovascular events. The BARI investigators observed that 80% of culprit lesions are located within the first 6 cm of the major coronary arteries. 10 Several large studies on calcified coronary plaque indicate that the amount of plaque is a very potent indicator of increased cardiovascular risk beyond the presence of luminal obstruction and traditional risk factors. 11 Recently, a population based trial demonstrated an eight-fold increase in relative risk for cardiovascular events over 3 y in patients-significant plaque burden (Agatston Score (AS) 4100). 12 Moreover, patients without any coronary plaque have a very low likelihood of future cardiovascular events.
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Remodeling and stenosis Vascular remodeling is a bidirectional process. Ruptureprone plaques with large lipid-rich core and a thin cap are relatively large and associated with compensatory enlargement known as positive remodeling. This tends to preserve adequate lumen despite significant atherosclerosis. Plaques responsible for stable angina are may be smaller but often causes severe luminal narrowing due to local shrinkage of the artery called negative remodeling.
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Neovascularization Neovascularization is often present at the base of advanced plaques. It is felt that these new vessels could play an active role in the recruitment of proinflammatory cells and thus contribute to the progression of the plaque. Even in the presence of plaque surface integrity, small hemorrhages are common in these neovascularized areas.
Clinical utility of plaque detection
The current strategies for prediction of cardiovascular risk do not include morphological information on the presence and severity of coronary artery disease. Clinical approaches emphasize traditional risk factors such as the patient's age, sex, and the presence and extent of established, modifiable coronary risk factors such as hypertension, hyperlipidemia, diabetes mellitus, cigarette smoking in the prediction, and reduction of coronary risk. 24 Risk prediction algorithms, such as the Framingham Heart Study coronary risk score, have been shown to be a valid, generalizable tool for risk prediction, 24 and current treatment guidelines have incorporated traditional risk factors and/or risk factor algorithms into recommendations for initiation of drug therapy for hypertension and hyperlipidemia. 25, 26 Coronary risk scores are relatively sensitive but not highly specific. Therefore, their use in clinical practice is still limited. In fact, traditional coronary risk factors may be insensitive to the significant heterogeneity of atherosclerotic coronary plaque burden in individuals.
Since almost 50% of patients with acute myocardial infarction suffer from sudden death before they can reach a hospital, researchers have focused on the detection and characterization of plaques that are prone to rupture (vulnerable plaques). Histopathology studies in sudden death victims have characterized the vulnerable plaque as composed of a thin fibrous cap with a large underlying lipid pool, and dense infiltration of activated macrophages in shoulder regions of the cap. 27 Although calcification can be found in almost 50% of ruptured plaques, it remains unclear whether it stabilizes plaque and represents a process of plaque healing. 28, 29 However, the detection and characterization of noncalcified plaque is especially interesting. Several angiographic studies suggest that both the number of lesions and complex lesion morphology (450% stenosis, presence of intracoronary thrombus, eccentricity, surface irregularities) are associated with adverse outcomes. [30] [31] [32] [33] Therefore, there is currently a significant interest in detection of coronary plaques from both research and clinical purposes. A noninvasive method for visualization and quantification of atherosclerotic plaque burden within the entire coronary artery tree could provide the ability to assess the natural history of coronary artery disease and the response of plaque progression to therapy. If successful, such a method could provide novel insight into coronary disease and help identify patients at risk for adverse coronary events. 34 High-resolution CT imaging is a unique opportunity to noninvasively detect coronary artery plaque burden and allows direct detection and quantification of calcified atherosclerotic plaques within the coronary arteries, independent of the presence of significant hemodynamic obstruction due to arterial luminal stenosis. In the past decade, a small but growing number of prospective studies have been conducted in order to examine the potential of coronary calcium measurements by CT to serve as a predictor for coronary risk, as a tool to follow the natural history of coronary atherosclerosis and to track the dynamics under several treatment strategies for CAD.
Imaging of atherosclerotic plaques
There are multiple invasive modalities that have been utilized to assess coronary plaques. A common disadvantage of all these procedure is the high cost, a substantial procedural morbidity and mortality, and that these procedures are only justified in intermediate to high-risk symptomatic patients. Coronary angiography currently is the gold standard for diagnosing occlusive coronary artery disease. Although irregular coronary lumen suggest plaque burden, this technology has significant limitation in terms of nonstenotic plaque detection including lack of data regarding vessel wall, composition of the plaque, and in case of diffuse coronary disease, underestimating the severity of plaque burden. Moreover, one cannot detect positive remodeling seen in the early stages of plaque development. 35 Thus, absence of significant coronary artery disease by cardiac catheterization does not provide any information on the presence of coronary atherosclerotic process per se. These deficiencies can be overcome by introducing an intravascular ultrasound (IVUS) in the coronary arteries. 36 These catheter-based ultrasound devices provides crosssectional images of the coronary artery lumen and wall with an in-plane resolution of 80-150 mm. This method has been shown to be highly accurate to detect coronary atherosclerotic plaque ex vivo compared to histology [37] [38] [39] [40] and in patients. 41 IVUS can accurately quantify plaque burden 41 and remodeling of the coronary artery wall, measure distensibility of plaques, 42, 43 and monitor effects of lipidlowering therapy. 44, 45 Some researchers suggest that IVUS can distinguish fibrous, lipid, and calcified regions.
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Based on plaque echogenecity, coronary plaques can then be divided into three groups; highly echo-reflective (calcified), hyperechoic (fibrosis or microcalcification, and hypoechoic (thormbotic or lipid laden). Since IVUS is an invasive technique, it can only be used clinically in patients that undergo coronary angiography. Optical coherence tomography (OCT) is an invasive investigational method similar to IVUS that uses light interferometry to visualize subsurface structure in biological Noninvasive detection of coronary atherosclerotic plaque U Hoffmann and J Butler tissue. 48 Objective OCT criteria are highly sensitive and specific for characterizing different types of atherosclerotic plaques. 49 In particular, the high contrast and spatial resolution (10-20 mm) enable OCT to differentiate plaque into fibrous, lipid, and calcified components.
Other invasive methods to assess coronary plaques include angioscopy (allowing direct visualization of the plaques surface), and thermography (assessing temperature), Raman spectroscopy and near-infrared spectroscopy (both techniques utilized to assess plaque composition). [50] [51] [52] [53] [54] [55] A noninvasive method for visualization and quantification of atherosclerotic plaque burden within the entire coronary artery tree could provide the ability to observe the natural history of coronary artery disease and to assess the response of coronary atherosclerotic plaque to medical therapy such as lipid lowering. If successful, such a method would provide novel insight into coronary artery disease and has the potential to improve risk stratification for coronary events.
Computed tomography (CT)
There has been a growing interest in assessment of plaque burden with the use of CT. Most literature in this respect is indirect assessment of coronary plaque burden by way of assessing the vessel wall calcium deposition using electron beam CT (EBCT). 56 The amount of calcium is generally expressed as an AS. The AS is calculated by multiplying the area of each lesion with a weighted CT attenuation score dependent on the maximal CT attenuation (HU) within a lesion as described elsewhere. 8 The method for calculation of the AS is similar for multidetector CT (MDCT) and EBCT. [57] [58] [59] [60] However, previous research has demonstrated that especially small lesions (ASo10) may have a different AS in EBCT vs MDCT due to differences in scanner specifications between the two modalities (ie, different temporal resolution, slice thickness, and tube current: 100 ms, 3 mm, and 625 mA for EBCT; respectively, and 330 ms, 2.5 mm, and 300 mA for MDCT; respectively). 60, 61 A small number of prospective studies have evaluated the prediction of cardiac events by coronary calcification. These studies suggest that individuals with AS 4400 have an increased occurrence of coronary procedures (bypass, stent placement, angioplasty), and hard coronary events (myocardial infarction and cardiac death) within the 2-5 y following the test. Individuals with very high AS (over 1000) have a 20% chance of suffering a myocardial infarction or cardiac death within a year. Even among elderly patients (470 y), who frequently have calcification, an AS 4400 was associated with a higher risk of death. In addition, patients with diabetes, familial hypercholesterolemia, or retinopathy have both extremely high amounts of coronary calcium and a high event rate. In a recent meta-analysis of prospective studies, there was an increased risk for a combined outcome (nonfatal MI, CHD death, or revascularization) associated with a calcium score elevated above a median value (risk ratio 8.7 [95% CI, 2.7-28.1]). The relative risk of hard endpoints (MI or death) was also increased (risk ratio 4.2 [95% CI 1.6-11.3]). 56 While available research data suggest that the coronary event risk appears to be related primarily to extent of atherosclerosis as reflected in the total plaque burden (ie, AS for calcified plaque), it is conceivable that the detection of noncalcified plaque may be more accurate to predict event risk. Currently, the only available clinical method to assess and quantify noncalcified coronary plaque in vivo is invasive IVUS. However, recent data in this respect with MDCT is encouraging. Advances in MDCT technology with submillimeter slice collimation (B0.6 mm) and high temporal resolution now permit contrast-enhanced imaging of the coronary artery lumen and wall in a single breath hold. The current generation of MDCT provided in-plane resolution of 0.5 mm and a temporal resolution of 210 ms. The simultaneous acquisition of 16/64 parallel cross-sections reduce image acquisition time to about 10-20 s for 16/64-slice MDCT and subsequently decrease the amount of contrast necessary to opacify the coronary artery lumen to 60-80 ml. Our group and others have reported excellent diagnostic accuracy on the detection of significant stenosis in coronary segments with high image quality (92% sensitivity, 93% specificity) and, more importantly, for all coronary segments (84% sensitivity, 85% specificity) and per patient (91% sensitivity, 82% specificity) as compared with coronary angiography. [62] [63] [64] [65] [66] [67] In addition to the delineation of the coronary artery lumen and the detection of coronary stenosis cardiac MDCT also permits the visualization of atherosclerotic plaque throughout the coronary vessel tree.
Plaque determination with MDCT
Literature, though still early, is growing rapidly regarding the utility of MDCT in coronary plaque determination. However, it is a moving target and data are difficult to assimilate as different investigators have either used varying scanners (4 vs 16 vs 64 slice) or compared results to either IVUS or histological samples. Also, literature continues to emerge with respect to plaque detection, plaque volume assessment, and plaque characteristic assessment with MDCT. Earlier studies using 4-slice MDCT demonstrated that noncalcified plaque can be detected in a considerable fraction of patients without calcified plaque. 68 Caussin et al 69 reported that noncalcified plaques were present in all patients of a small series who presented with clinical myocardial infarction but had near normal coronary artery disease.
In addition, the ability to characterize plaque composition has been investigated ex vivo. These studies suggested that MDCT can differentiate between noncalcified lipid laden, noncalcified fibrous, and calcified plaques, based on significant differences in HU measurements. 70, 71 Subsequently, several studies have reported the sensitivity and specificity of MDCT detection of plaques as compared to IVUS using the 16-slice MDCT scanners. Our group has Noninvasive detection of coronary atherosclerotic plaque U Hoffmann and J Butler shown an overall detection of any plaque sensitivity of 82% and specificity of 88%; a 94% sensitivity and specificity for calcified plaques; and 78% sensitivity and 87% specificity for noncalcified plaques when compared against IVUS. (Figure 1 ) Limited assessment of only the proximal segments showed a sensitivity and specificity of 92 and 88% for all plaques, 95 and 91% for calcified plaques, and 91 and 89% for noncalcified plaques, respectively. MDCT did however underestimate the volume of plaques as compared to IVUS. 72 These data have been recently supported and extended by Leber et al 73 , who state that noncalcified plaque as detected by MDCT can be differentiated accurately into hyperechoic and hypoechoic plaque (sensitivity both 78%) as compared to IVUS based on CT density values. The specificity for overall plaque detection measured in 3 mm segments was excellent (specificity 92%). The CT density for hypoechoic lesions was 49722 HU, for hyperechoic lesions 91722 HU, and for calcified plaques 3917156 HU. Other studies from our lab also suggest that the measurement of coronary remodeling is possible. 19 Although a close correlation was found and good accuracy of MDCT measurements of the cross-sectional coronary artery lumen area in comparison to IVUS were demonstrated, correlation for measurement of atherosclerotic plaque area appears to be moderate in these studies. Also, the presence of calcium proved to impair the MDCT measurement accuracy of plaque dimensions. Our data confirms the high accuracy of MDCT coronary artery lumen measurements described before based on comparisons to quantitative, X-ray coronary angiography. 74 In one prior study, a significant underestimation of plaque volume per coronary segment was reported for MDCT as compared to IVUS, 73 while we observed overestimation of plaque areas by MDCT. 75 This difference is explained by different settings used for the display of MDCT images and by the fact that failure to detect plaque in some cross-sections by MDCT led to an underestimation of plaque volume per segment in the earlier study. Overestimation of plaque dimensions by MDCT has also been reported in a phantom study and has been attributed to partial volume effects. Noninvasive detection of coronary atherosclerotic plaque U Hoffmann and J Butler
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CT imaging in children/adolescents
Several studies in adolescents with familial hypercholesterolemia demonstrated the presence of early atherosclerotic disease such as endothelial dysfunction or noncalcified atherosclerotic plaque whereas calcified plaques are rarely found at this age. Potentially noninvasive CT-based plaque imaging could identify the presence and extent of noncalcified atherosclerotic plaque also in obese children. However, radiation exposure and dye administration remains conceptual limitations of CT, particularly in children. It remains to be determined whether plaque detection by CT has the potential to improve risk stratification or guide therapy in obese children.
Limitations
A number of limitations exist with respect to currently available data. In the published studies only high-quality images (absence of artifacts caused by motion and severe calcification) most often from proximal coronary arteries were considered for this analysis, accuracy in unselected data would obviously be lower. Also, delineation of plaque is so far based on subjective assessment using empirically determined image display settings (ie window 500 HU, level 150 HU) for display of and measurements. The value of individualized settings, especially for plaque measurements, needs to be determined.
Conclusion
The results indicate that high-resolution MDCT can accurately detect calcified and mixed coronary atherosclerotic plaque throughout the coronary tree in patients without significant coronary stenoses. Plaque quantification is more difficult in partially or wholly calcified plaques. Based on the CT density of the lesions, there continues to be excitement in using this modality to also characterize the atherosclerotic plaque, however, more data are needed. The ability of MDCT to detect and measure coronary atherosclerotic plaque is expected to improve with the introduction of 64-slice MDCT technology with improved temporal and spatial resolution.
